ideasbyjin
commited on
Commit
•
0b4965f
1
Parent(s):
90af908
Prettify license table
Browse files- LICENSE.md +3 -3
LICENSE.md
CHANGED
@@ -5,9 +5,9 @@ AntiBERTa2 models are antibody-specific Large Language Models (LLM) developed by
|
|
5 |
|
6 |
Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights, available for use, reproduction and distribution under this modified version of the Apache 2.0 Licence.
|
7 |
|
8 |
-
|
9 |
-
| --- | ------ | --- |
|
10 |
| Permissions | Limitations | Conditions |
|
|
|
11 |
| Private use | No commercial use | Attaching this license |
|
12 |
| Research and academic use | No use for pre-clinical or clinical tests or studies | Notices |
|
13 |
| Creating antibody variants | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for **in vitro** or **in vivo** studies | Attribution |
|
@@ -16,7 +16,7 @@ Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights,
|
|
16 |
| Distribution | |
|
17 |
|
18 |
|
19 |
-
TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF FABCON
|
20 |
1. Definitions.
|
21 |
"License" shall mean these terms and conditions for use, reproduction, and distribution of the Work as defined by Sections 1 through 9 of this document.
|
22 |
"Licensor" shall mean Alchemab Therapeutics Ltd, the copyright owner or entity authorized by the copyright owner that is granting the License.
|
|
|
5 |
|
6 |
Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights, available for use, reproduction and distribution under this modified version of the Apache 2.0 Licence.
|
7 |
|
8 |
+
## LICENSE SUMMARY
|
|
|
9 |
| Permissions | Limitations | Conditions |
|
10 |
+
| ----------- | ---------- | ---------- |
|
11 |
| Private use | No commercial use | Attaching this license |
|
12 |
| Research and academic use | No use for pre-clinical or clinical tests or studies | Notices |
|
13 |
| Creating antibody variants | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for **in vitro** or **in vivo** studies | Attribution |
|
|
|
16 |
| Distribution | |
|
17 |
|
18 |
|
19 |
+
## TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF FABCON
|
20 |
1. Definitions.
|
21 |
"License" shall mean these terms and conditions for use, reproduction, and distribution of the Work as defined by Sections 1 through 9 of this document.
|
22 |
"Licensor" shall mean Alchemab Therapeutics Ltd, the copyright owner or entity authorized by the copyright owner that is granting the License.
|